Berman Capital Advisors’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Berman Capital Advisors’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3K	Buy	+26	New	+$7.88K	﹤0.01%	1639

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Berman Capital Advisors's MDVL Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2021: 26 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1639 among its holdings.

49 funds tracked by Wall St. Rank hold MDVL as of Q3 2021.

Berman Capital Advisors held 26 shares of MedAvail Holdings, Inc. Common Stock worth $3K as of Q3 2021.
MedAvail Holdings, Inc. Common Stock was a new Berman Capital Advisors position in Q3 2021.
MedAvail Holdings, Inc. Common Stock made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1639 holding.
49 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.